CanSino Biologics Inc (CASBF)
2.10
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
CanSino Biologics Total Assets (Quarterly): 1.204B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.204B |
| December 31, 2023 | 1.315B |
| September 30, 2023 | 1.317B |
| June 30, 2023 | 1.364B |
| June 30, 2023 | 1.364B |
| December 31, 2022 | 1.662B |
| June 30, 2022 | 1.789B |
| June 30, 2022 | 1.789B |
| December 31, 2021 | 1.863B |
| Date | Value |
|---|---|
| June 30, 2021 | 1.586B |
| June 30, 2021 | 1.586B |
| December 31, 2020 | 1.033B |
| June 30, 2020 | 241.23M |
| June 30, 2020 | 241.23M |
| December 31, 2019 | 255.04M |
| June 30, 2019 | 268.59M |
| June 30, 2019 | 268.59M |
| December 31, 2018 | 115.70M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
241.23M
Minimum
Jun 2020
1.863B
Maximum
Dec 2021
1.126B
Average
1.317B
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 13.66B |
| CASI Pharmaceuticals Inc | 75.27M |
| Zai Lab Ltd | 988.44M |
| Gracell Biotechnologies Inc (DELISTED) | 259.03M |
| Adagene Inc | 115.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 486.51M |
| Shareholders Equity (Quarterly) | 717.58M |
| Debt to Equity Ratio | 0.412 |
| Current Ratio | 2.389 |
| Net Debt Paydown Yield | 2.61% |